Esther Krug is an Endocrinology/Metabolic physician affiliated with Sinai Hospital. OpenAlex indexes 17 publications with 296 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2435 W Belvedere Ave
Suite 56
Baltimore, MD 212155224
Telephone
410-601-5961Provider last certified this registry record 17 Mar 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amphastar Pharmaceuticals, Inc.Program year20252 payments
- Novo Nordisk IncProgram year20231 payment
- Medtronic, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
59.5%RANK Ligand Inhibitor58.4%Denosumab98%Prolia2%Part D + Part B≥60 patientsXanthine oxidase inhibitor0.7%Allopurinol100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
21.2%GLP-1 receptor agonist5.4%Ozempic48%Trulicity39%Mounjaro13%Part D≥40 patientsBiguanide (metformin)3.9%Metformin Hcl Er81%Metformin Hcl19%Part D≥65 patients+ 12 more classes in this area
Cardiovascular
10.1%Statin3.4%Rosuvastatin Calcium84%Atorvastatin Calcium12%Crestor5%Part D<11 patientsAngiotensin receptor blocker (ARB)1.5%Losartan Potassium38%Losartan-Hydrochlorothiazide23%Valsartan12%Telmisartan-Hydrochlorothiazid10%Irbesartan-Hydrochlorothiazide9%Valsartan-Hydrochlorothiazide9%Part D<11 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SUN-545 Diabetes & Mitochondrial Dysfunction: A Case of G[3243] Mutation with MELAS Potential
Journal of the Endocrine Society
2025 - MON-119 Lymphocytic Hypophysitis in an Adolescent Female: Diagnostic Challenges and Therapeutic Response
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Henry Fein, MD
Sinai Hospital
Debra Counts, MD
Sinai Hospital
Ira Garonzik, MD
Sinai Hospital
Donald Abrams, MD
Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”